Future Trends and Developments in the Pharmaceuticals Industry in France.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c53280) has announced the addition of "Pharmaceuticals in France" to their offering.

Our Pharmaceuticals in France industry profile is an essential resource for top-level data and analysis covering the Pharmaceuticals industry.

Scope of this title:

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and leading companies

* Includes a five-year forecast of the industry

* Supported by the key macroeconomic and demographic data affecting the market

Highlights of this title:

* Detailed information is included on market size, measured by both value and volume

* Market shares are covered by manufacturer and/or brand

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition -- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2005 annual average exchange rates.

Market shares are for sales in 2005, the most recent full year results available.

For the purpose of this report, the European market is deemed to consist of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Areas covered include:

* Market overview

* Market value

* Market segmentation

* Market share

* Competitive landscape

* Leading companies

* Market forecasts

* Macroeconomic indicators

* Further reading

Companies mentioned:

* Sanofi-Aventis Group

* Pfizer Inc

* GlaxoSmithKline Plc

* AstraZeneca PLC

For more information visit http://www.researchandmarkets.com/reports/c53280.

Source: Datamonitor